Asprosin neutralizing antibodies as a treatment for metabolic syndrome

  1. Ila Mishra
  2. Clemens Duerrschmid
  3. Zhiqiang Ku
  4. Yang He
  5. Wei Xie
  6. Elizabeth Sabath Silva
  7. Jennifer Hoffman
  8. Wei Xin
  9. Ningyan Zhang
  10. Yong Xu
  11. Zhiqiang An
  12. Atul R Chopra  Is a corresponding author
  1. Case Western Reserve University, United States
  2. University of Texas Health Science Center at Houston, United States
  3. Baylor College of Medicine, United States
  4. Case Western Reserve University,, United States
  5. Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, TX, United States
  6. Brown Foundation Institute of Molecular Medicine, United States
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/63784/elife-63784-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ila Mishra
  2. Clemens Duerrschmid
  3. Zhiqiang Ku
  4. Yang He
  5. Wei Xie
  6. Elizabeth Sabath Silva
  7. Jennifer Hoffman
  8. Wei Xin
  9. Ningyan Zhang
  10. Yong Xu
  11. Zhiqiang An
  12. Atul R Chopra
(2021)
Asprosin neutralizing antibodies as a treatment for metabolic syndrome
eLife 10:e63784.
https://doi.org/10.7554/eLife.63784